These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18021599)

  • 21. [Preservative allergy : An enduring issue].
    Kreft B; Geier J
    Hautarzt; 2020 Mar; 71(3):190-196. PubMed ID: 31792581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methyldibromoglutaronitrile is an important contact allergen in The Netherlands.
    de Groot AC; de Cock PA; Coenraads PJ; van Ginkel CJ; Jagtman BA; van Joost T; Joost van der Kley AM; Meinardi MM; Smeenk G; van der Valk PG; van der Walle HB; Weyland JW
    Contact Dermatitis; 1996 Feb; 34(2):118-20. PubMed ID: 8681539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreasing trends in methyldibromo glutaronitrile contact allergy--following regulatory intervention.
    Johansen JD; Veien N; Laurberg G; Avnstorp C; Kaaber K; Andersen KE; Paulsen E; Sommerlund M; Thormann J; Nielsen NH; Vissing S; Kristensen O; Kristensen B; Agner T; Menné T
    Contact Dermatitis; 2008 Jul; 59(1):48-51. PubMed ID: 18537990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative repeated open application testing with a rinse-off product in methyldibromo glutaronitrile-sensitive patients: results of the IVDK.
    Heratizadeh A; Killig C; Worm M; Soost S; Simon D; Bauer A; Mahler V; Schuster C; Szliska C; Frambach Y; Eben R; Werfel T; Uter W; Schnuch A
    Contact Dermatitis; 2010 Jun; 62(6):330-7. PubMed ID: 20557338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should methyldibromo glutaronitrile continue to be used in the European baseline Series? A REIDAC national cross-sectional study.
    Mercader-García P; Pastor-Nieto MA; Gonzalez-Perez R; Cordoba-Guijarro S; Gimenez-Arnau AM; Ruiz-Gonzalez I; Mora-Fernández V; Miquel J; Silvestre-Salvador JF; Ortiz-Frutos FJ; Sanz-Sanchez T; Rodriguez-Serna M; Perez-Feal P; Sánchez-Pérez J; Heras-Mendaza F; Serra-Baldrich E; Zaragoza-Ninet V; Hervella-Garces M; Gatica-Ortega ME; García-Doval I; Descalzo MÁ; Borrego L;
    Contact Dermatitis; 2021 Nov; 85(5):572-577. PubMed ID: 33745152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patch testing with a new fragrance mix - reactivity to the individual constituents and chemical detection in relevant cosmetic products.
    Frosch PJ; Rastogi SC; Pirker C; Brinkmeier T; Andersen KE; Bruze M; Svedman C; Goossens A; White IR; Uter W; Arnau EG; Lepoittevin JP; Johansen JD; Menne T
    Contact Dermatitis; 2005 Apr; 52(4):216-25. PubMed ID: 15859994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allergic contact dermatitis from methyldibromo glutaronitrile in a sanitary pad and review of Australian clinic data.
    Williams JD; Frowen KE; Nixon RL
    Contact Dermatitis; 2007 Mar; 56(3):164-7. PubMed ID: 17295694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patch testing with methyldibromoglutaronitrile in a localized population in the United States.
    Javvaji S; Belsito DV
    Dermatitis; 2010; 21(6):321-6. PubMed ID: 21144344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allergic contact dermatitis from methyldibromo glutaronitrile--clinical cases from 2003.
    Zachariae C; Johansen JD; Rastogi SC; Menné T
    Contact Dermatitis; 2005 Jan; 52(1):6-8. PubMed ID: 15701121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methyldibromo glutaronitrile contact allergy: effect of single versus repeated daily exposure.
    Jensen CD; J Ohansen JD; Menné T; Andersen KE
    Contact Dermatitis; 2005 Feb; 52(2):88-92. PubMed ID: 15725286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a questionnaire algorithm based on repeated open application testing with the constituents of fragrance mix I.
    Bruze M; Engfeldt M; Ofenloch R; Elsner P; Goncalo M; Isaksson M; Naldi L; Schuttelaar ML; Svensson Å; Diepgen T
    Br J Dermatol; 2020 Apr; 182(4):955-964. PubMed ID: 31206595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allergic reactivity for different dilutions of eugenol in repeated open application test and patch testing.
    Ofenloch RF; Andersen KE; Foti C; Giménez-Arnau AM; Mowitz M; Salvador JFS; Svedman C; Bruze M
    Contact Dermatitis; 2023 Aug; 89(2):95-102. PubMed ID: 37218587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of a detergent on skin response to methyldibromo glutaronitrile in sensitized individuals.
    Pedersen LK; Haslund P; Johansen JD; Held E; Vølund A; Agner T
    Contact Dermatitis; 2004 Jan; 50(1):1-5. PubMed ID: 15059095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patch test results with the metalworking fluid series of the German Contact Dermatitis Research Group (DKG).
    Geier J; Lessmann H; Dickel H; Frosch PJ; Koch P; Becker D; Jappe U; Aberer W; Schnuch A; Uter W
    Contact Dermatitis; 2004 Sep; 51(3):118-30. PubMed ID: 15479200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is the optimal duration for a ROAT? The experience of the French Dermatology and Allergology group (DAG).
    Amsler E; Assier H; Soria A; Bara C; Ferrier le Bouëdec MC; Barbaud A; Milpied B; Giordano-Labadie F; Pasteur J; Badaoui A; Valois A; Castelain F; Kurihara F; Castagna J; Boulard C; Bernier C; Leleu C; Marcant P; Crépy MN; Tetart F; Raison-Peyron N;
    Contact Dermatitis; 2022 Aug; 87(2):170-175. PubMed ID: 35383393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxyisohexyl 3-cyclohexene carboxaldehyde allergy: relationship between patch test and repeated open application test thresholds.
    Fischer LA; Menné T; Avnstorp C; Kasting GB; Johansen JD
    Br J Dermatol; 2009 Sep; 161(3):560-7. PubMed ID: 19486000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methyldibromoglutaronitrile (Euxyl K400): a new and important sensitizer in the United States?
    Jackson JM; Fowler JF
    J Am Acad Dermatol; 1998 Jun; 38(6 Pt 1):934-7. PubMed ID: 9632000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative aspects of isoeugenol contact allergy assessed by use and patch tests.
    Johansen JD; Andersen KE; Menné T
    Contact Dermatitis; 1996 Jun; 34(6):414-8. PubMed ID: 8879928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A further characteristic of susceptibility to contact allergy: sensitization to a weak contact allergen is associated with polysensitization. Results of the IVDK.
    Schnuch A; Brasch J; Lessmann H; Geier J; Uter W
    Contact Dermatitis; 2007 Jun; 56(6):331-7. PubMed ID: 17577374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study aimed at finding a suitable eugenol concentration for a leave-on product for use in a repeated open application test.
    Svedman C; Engfeldt M; Api AM; Politano VT; Belsito DV; Isaksson M; Bruze M
    Contact Dermatitis; 2012 Mar; 66(3):137-9. PubMed ID: 22320668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.